SlideShare a Scribd company logo
Creating a Targeted Next Generation Sequencing Assay to Identify RH antigens from DNA for
Stem Cell Transplants
Abigail Joseph
Principal Investigator:​ William Lane MD, PhD
Mentors:​ Peter Tonellato PhD; Helen Mah, MS; John ​Baronas
Dana-Farber Cancer Institute
Using DNA assays to determine human leukocyte antigen (HLA) type is standard practice when
seeking to find stem cell transplant donor matches. Recently, next generation sequencing
(NGS) has been successfully developed to perform accurate HLA typing. As a result, stem cell
donors are typed using DNA samples collected with cheek swab kits. ABO and Rh mismatches
between donor and recipient can result in major and minor incompatibilities that can delay
erythroid engraftment and require multiple rounds of red blood cell (RBC) transfusions. An ABO
and Rh NGS assay could improve the stem cell transplant matching process because only DNA
samples are collected from prospective donors. However, one major obstacle in using NGS to
determine the presence of Rh antigens from DNA is the similarity between the ​RHD and ​RHCE
genes. The objective of our experiment was to determine whether a targeted NGS assay could
be developed to determine the specific Rh antigens in a patient’s RBCs. We performed long
range PCRs to test optimal primer combinations for successful amplification of the genes. Gene
specific indexes were added to the ​RHD and ​RHCE PCR products, prior to sequencing, so
identical regions of the genes could be clearly labeled. The results of the sequence alignments
showed that the primers that targeted ​RHD exons 1-6 and ​RHCE exons 1-4 resulted in the
largest PCR products while maintaining strong alignment coverage. In addition, the DNA reads
aligned according to our expectations allowing us to predict the patient’s antigen type as D
antigen positive, homozygous for the C antigen, and homozygous for the e antigen. These
findings suggest that Rh antigens can be determined from DNA assays without serologic
testing. Consequently, the same DNA sample used for HLA typing can be used for Rh antigen
typing, thus streamlining the stem cell donor match process.
Currently HLA (human Leukocyte Antigen) typing is done completely from DNA
● However, RBC antigens still cannot be determined from DNA and must be confirmed
serologically
● This hinders the process of finding donors for Stem Cell Transplant,
○ Although a DNA sample, such as spit or cheek cells, that are sent in can be used
to determine a potential donor's HLA type, that same sample can’t be used to
determine RBC type
○ Donor must physically come in to donate blood and test must be done
serologically, which is time consuming and expensive
● This is especially relevant for patients with leukemia or Lymphoma who need Stem Cell
Transplants since their immune systems were eliminated in the treatment process
● There is a need to find exact matches or else the patient is at risk for HTR (hemolytic
Transfusion Reaction) or GvHD (Graft vs. Host Disease)
● Purpose is to create a targeted assay that uses Next Generation Sequencing to confirm
RH, RhD and RhCE, antigens on RBC similar to how HLAs are confirmed
● Then theoretically one DNA sample could be used to find the most promising exact HLA
and RBC antigen matches, so only a few would have to be brought in for serologically
confirmation of the DNA results.
● Problem with current attempts to sequence the RhD and RhCE is that they are very
similar gene and standard methods of hybrid capture and amplicon sequencing do not
work
○ Some parts of RhD and RhCE are so similar so sequencing without long enoug
reads can fail to identify which DNA come from RhD and which from RhCE
● The approach we used is very long range PCR
○ It can create gene specific sequences, which circumvents the problem that the
genes look very similar
○ By allowing us to add gene specific tags so we can know which gene it came
from when sequencing
● First step is find a primer that would amplify the Rhd gene DNA
○ Looked at PCR products to determine size and quantity
● Next the goal is to sequence the DNA, using an illumina miseq,
● Take sequencing data dn see which genes they align to
● Last is to examine the sequencing data using a software to determine whether the
sequencing allows us to conclude that the someone has an RhD antigen or if the
sequencing is inconclusive
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926707/
Picture
http://fce-study.netdna-ssl.com/2/images/upload-flashcards/10/70/84/9107084_m.jpg
http://img.medscapestatic.com/pi/meds/ckb/47/9947tn.jpg
http://path.upmc.edu/cases/case101/images/gross5.jpg
Presentation
I. Intro
A. What are the consequences of not matching type when giving stem cell
transplants
1. Stem Cell transplants are typically given to leukemia and lymphoma
cancer patients, who have had their immune systems destroyed by
treatment and need the transplants to replenish their immune system
2. GvHD (graft vs. Host Disease)
a) Diseases can be fatal
3. HDFN or HTR for RBC
B. How can DNA help provide more accurate blood typing?
1. For the past 5 yrs HLA (human leukocyte antigens) aka white blood cell
antigens have been typed completely from DNA
2. No longer needs to be done serologically, time consuming process, prone
to human error, expensive lab procedures and reagents
3. However RBC (red blood cell) typing still cannot be confirmed from a DNA
sample but must be tested serologically
C. Our question
1. We chose to look at the RhD and RhCE antigens, to determine whether
we could create a targeted NGS assay to reliably determine the D, C, c,
E, e antigens present on a patient's RBC from a DNA smaple
a) Explain what D anitgen is, determine (+) or (-) blood type
2. These antigens are especially problematic to determine with DNA
sequencing because they are very similar to each other, they can even
containing completely identical exons, and often sequences from one
gene can align to another, for accurate typing it is essential that reads
(sequences) align to the appropriate gene
II. Set Up -​ ask for Illumina Prep procedure
A. Before we could sequence the RhD and RhCE genes we had to determine which
primers would give us the highest concentration of the genes and the most
accurate “cuts”
1. We focused only on the first 7 exons in both - ​WHY
B. Performed 12 very long range PCR for each RhD and RhCE with different
primers, and used a gel to determine how much volume was produced, and a
standard to approximate the length of the DNA strands
1. Show image of PCR explain how each well increases in size as it
contains more exons
C. Before putting the the DNA in the Illumina miseq, we tagged the DNA that was
Rhd and that was RhCE, with different tags, so at the end of the process we
know which DNA came from where
1. How does the tagging work???
D. The Illumina miseq take about 22 hrs to sequence the gene and then we
download the data into IGV (Integrative Genomics Viewer) to analyze the
success of each of the different primer set combinations
III. Data and Interpretation
A. Show the what the RhD and RhCE look like on one of the most successful trials
and one of the mediocre trials
1. Explain how to tell whether someone has high or low coverage
2. Maybe how to determine their genotype from the one base pair
3. Explain why there might be low coverage
a) Misalignment - graphic from Dr. Lanes Slide
IV. Context and Importance and Future Directions
A. Only 1 of the more than 300 RBC antigens, however it's the most important
antigen after the ABO group
B. When searching for Donors, in the future one sample of spit or cheek swab would
allow a doctor to determine your entire specific blood type,

More Related Content

What's hot

Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
Dr.Mangesh Dagawal
 
SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
 SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
ijcsa
 
Festival Of Genomics 2016 - Brain talk
Festival Of Genomics 2016 - Brain talkFestival Of Genomics 2016 - Brain talk
Festival Of Genomics 2016 - Brain talk
Jean Fan
 
Cloning vector
Cloning vectorCloning vector
Cloning vector
GKM
 
Tests In Organ Transplantation
Tests In Organ Transplantation Tests In Organ Transplantation
Tests In Organ Transplantation Shahin Hameed
 
Gene Editing for everyone
Gene Editing for everyoneGene Editing for everyone
Gene Editing for everyone
Mike Jowett
 
Characterization of RNA binding protein RBPMS as a novel marker for retinal ...
Characterization of RNA binding protein RBPMS  as a novel marker for retinal ...Characterization of RNA binding protein RBPMS  as a novel marker for retinal ...
Characterization of RNA binding protein RBPMS as a novel marker for retinal ...
Lior Schenk
 
140127 platinum genomes pedigree analyses
140127 platinum genomes pedigree analyses140127 platinum genomes pedigree analyses
140127 platinum genomes pedigree analysesGenomeInABottle
 
Johanna_Edlund-Thesis-final
Johanna_Edlund-Thesis-finalJohanna_Edlund-Thesis-final
Johanna_Edlund-Thesis-finalJohanna Edlund
 
Bioo Scientific - Absolute Quantitation for RNA-Seq
Bioo Scientific - Absolute Quantitation for RNA-SeqBioo Scientific - Absolute Quantitation for RNA-Seq
Bioo Scientific - Absolute Quantitation for RNA-Seq
Bioo Scientific
 
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library PrepBioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
Bioo Scientific
 
Dna And Stuff (JC July 31, 2008)
Dna And Stuff (JC July 31, 2008)Dna And Stuff (JC July 31, 2008)
Dna And Stuff (JC July 31, 2008)
Anthony Salvagno
 
CSH SC 2015 - PAGODA talk
CSH SC 2015 - PAGODA talkCSH SC 2015 - PAGODA talk
CSH SC 2015 - PAGODA talk
Jean Fan
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the article
QIAGEN
 
Session 2 - Anti-d Reagents Selection & Qualification
Session 2 - Anti-d Reagents Selection & QualificationSession 2 - Anti-d Reagents Selection & Qualification
Session 2 - Anti-d Reagents Selection & QualificationQBD18940
 

What's hot (15)

Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
Genetic engineering lecture PPT- Dr. Mangesh Dagwal 2020
 
SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
 SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
SBVRLDNACOMP:AN EFFECTIVE DNA SEQUENCE COMPRESSION ALGORITHM
 
Festival Of Genomics 2016 - Brain talk
Festival Of Genomics 2016 - Brain talkFestival Of Genomics 2016 - Brain talk
Festival Of Genomics 2016 - Brain talk
 
Cloning vector
Cloning vectorCloning vector
Cloning vector
 
Tests In Organ Transplantation
Tests In Organ Transplantation Tests In Organ Transplantation
Tests In Organ Transplantation
 
Gene Editing for everyone
Gene Editing for everyoneGene Editing for everyone
Gene Editing for everyone
 
Characterization of RNA binding protein RBPMS as a novel marker for retinal ...
Characterization of RNA binding protein RBPMS  as a novel marker for retinal ...Characterization of RNA binding protein RBPMS  as a novel marker for retinal ...
Characterization of RNA binding protein RBPMS as a novel marker for retinal ...
 
140127 platinum genomes pedigree analyses
140127 platinum genomes pedigree analyses140127 platinum genomes pedigree analyses
140127 platinum genomes pedigree analyses
 
Johanna_Edlund-Thesis-final
Johanna_Edlund-Thesis-finalJohanna_Edlund-Thesis-final
Johanna_Edlund-Thesis-final
 
Bioo Scientific - Absolute Quantitation for RNA-Seq
Bioo Scientific - Absolute Quantitation for RNA-SeqBioo Scientific - Absolute Quantitation for RNA-Seq
Bioo Scientific - Absolute Quantitation for RNA-Seq
 
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library PrepBioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
Bioo Scientific - Simplify and Reduce Cost of mtDNA Isolation and Library Prep
 
Dna And Stuff (JC July 31, 2008)
Dna And Stuff (JC July 31, 2008)Dna And Stuff (JC July 31, 2008)
Dna And Stuff (JC July 31, 2008)
 
CSH SC 2015 - PAGODA talk
CSH SC 2015 - PAGODA talkCSH SC 2015 - PAGODA talk
CSH SC 2015 - PAGODA talk
 
miRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the articlemiRNA profiling from blood challenges and recommendations - Download the article
miRNA profiling from blood challenges and recommendations - Download the article
 
Session 2 - Anti-d Reagents Selection & Qualification
Session 2 - Anti-d Reagents Selection & QualificationSession 2 - Anti-d Reagents Selection & Qualification
Session 2 - Anti-d Reagents Selection & Qualification
 

Viewers also liked

Hr flyer 2015
Hr flyer 2015Hr flyer 2015
Hr flyer 2015
Christine Hall
 
Materials development
Materials developmentMaterials development
Materials development
Chris Fitzgerald
 
Web 2.0
Web 2.0Web 2.0
Кейс по таргетированной рекламе хитрый прием
Кейс  по таргетированной рекламе хитрый приемКейс  по таргетированной рекламе хитрый прием
Кейс по таргетированной рекламе хитрый прием
Татьяна Саидова
 
spring bed napollu
spring bed napolluspring bed napollu
spring bed napollu
surabaya spring
 
Resume-Satish Chand New(Al Rakha)
Resume-Satish Chand New(Al Rakha)Resume-Satish Chand New(Al Rakha)
Resume-Satish Chand New(Al Rakha)Satish Chand Sharma
 
Tema 2: la integración curricular de las TIC
Tema 2: la integración curricular de las TIC Tema 2: la integración curricular de las TIC
Tema 2: la integración curricular de las TIC
Belengisbe
 
Executive Summary of my work
Executive Summary of my workExecutive Summary of my work
Executive Summary of my workMargarita Andreou
 
Week ten visual arguments
Week ten  visual argumentsWeek ten  visual arguments
Week ten visual arguments
Erin Hovey
 
Palmarés v concurso ornitológico el aviario de ubeda
Palmarés v concurso ornitológico el aviario de ubedaPalmarés v concurso ornitológico el aviario de ubeda
Palmarés v concurso ornitológico el aviario de ubedaRamón Jesús Deutor Ruiz
 
MLS Control Costs and Retain HGP Strategy
MLS Control Costs and Retain HGP StrategyMLS Control Costs and Retain HGP Strategy
MLS Control Costs and Retain HGP Strategymartinkelman
 
Presentación Alan Turing mellorada- PAULA R
Presentación Alan Turing mellorada- PAULA RPresentación Alan Turing mellorada- PAULA R
Presentación Alan Turing mellorada- PAULA R
Paula Romero Aragunde
 
Tang 07 vsepr
Tang 07   vseprTang 07   vsepr
Tang 07 vsepr
mrtangextrahelp
 
Deep web
Deep webDeep web
Deep web
Grayther LM
 
Reapproaching Divestment
Reapproaching DivestmentReapproaching Divestment
Reapproaching DivestmentJoli Holmes
 

Viewers also liked (16)

Hr flyer 2015
Hr flyer 2015Hr flyer 2015
Hr flyer 2015
 
Materials development
Materials developmentMaterials development
Materials development
 
Web 2.0
Web 2.0Web 2.0
Web 2.0
 
Кейс по таргетированной рекламе хитрый прием
Кейс  по таргетированной рекламе хитрый приемКейс  по таргетированной рекламе хитрый прием
Кейс по таргетированной рекламе хитрый прием
 
spring bed napollu
spring bed napolluspring bed napollu
spring bed napollu
 
Asset basedsf
Asset basedsfAsset basedsf
Asset basedsf
 
Resume-Satish Chand New(Al Rakha)
Resume-Satish Chand New(Al Rakha)Resume-Satish Chand New(Al Rakha)
Resume-Satish Chand New(Al Rakha)
 
Tema 2: la integración curricular de las TIC
Tema 2: la integración curricular de las TIC Tema 2: la integración curricular de las TIC
Tema 2: la integración curricular de las TIC
 
Executive Summary of my work
Executive Summary of my workExecutive Summary of my work
Executive Summary of my work
 
Week ten visual arguments
Week ten  visual argumentsWeek ten  visual arguments
Week ten visual arguments
 
Palmarés v concurso ornitológico el aviario de ubeda
Palmarés v concurso ornitológico el aviario de ubedaPalmarés v concurso ornitológico el aviario de ubeda
Palmarés v concurso ornitológico el aviario de ubeda
 
MLS Control Costs and Retain HGP Strategy
MLS Control Costs and Retain HGP StrategyMLS Control Costs and Retain HGP Strategy
MLS Control Costs and Retain HGP Strategy
 
Presentación Alan Turing mellorada- PAULA R
Presentación Alan Turing mellorada- PAULA RPresentación Alan Turing mellorada- PAULA R
Presentación Alan Turing mellorada- PAULA R
 
Tang 07 vsepr
Tang 07   vseprTang 07   vsepr
Tang 07 vsepr
 
Deep web
Deep webDeep web
Deep web
 
Reapproaching Divestment
Reapproaching DivestmentReapproaching Divestment
Reapproaching Divestment
 

Similar to Abstract (1)

Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
Thermo Fisher Scientific
 
Science 2016 Poster 2016.10.20 FINAL
Science 2016 Poster 2016.10.20 FINALScience 2016 Poster 2016.10.20 FINAL
Science 2016 Poster 2016.10.20 FINALAndrew Warburton
 
TISSUE TYPING .pptx
TISSUE TYPING                       .pptxTISSUE TYPING                       .pptx
TISSUE TYPING .pptx
KARTHIK REDDY C A
 
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
MNDU net
 
Genome mapping
Genome mapping Genome mapping
Genome mapping
Rashmi Yadav
 
Polymerase Chain Reaction
Polymerase Chain ReactionPolymerase Chain Reaction
Polymerase Chain Reaction
sara_abudahab
 
Pcr and its applications in cloning
Pcr and its applications in cloningPcr and its applications in cloning
Pcr and its applications in cloning
Bahauddin Zakariya University lahore
 
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITEDSelene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITEDSelene Hess
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
Jamia Hamdard New Delhi
 
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
GenomeInABottle
 
Impact_of_gene_length_on_DEG
Impact_of_gene_length_on_DEGImpact_of_gene_length_on_DEG
Impact_of_gene_length_on_DEGLong Pei
 
3.5 part 1
3.5 part 13.5 part 1
3.5 part 1
lucascw
 
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
GenomeInABottle
 
-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf
RajendraChavhan3
 
-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf
RajendraChavhan3
 
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...Fatuma-Ayaan Rinderknecht
 

Similar to Abstract (1) (20)

CURE Presentation (1)
CURE Presentation (1)CURE Presentation (1)
CURE Presentation (1)
 
Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
Concurrent Determination of ABO RhD Blood Types and the HIV-1 Resistance Mark...
 
Science 2016 Poster 2016.10.20 FINAL
Science 2016 Poster 2016.10.20 FINALScience 2016 Poster 2016.10.20 FINAL
Science 2016 Poster 2016.10.20 FINAL
 
TISSUE TYPING .pptx
TISSUE TYPING                       .pptxTISSUE TYPING                       .pptx
TISSUE TYPING .pptx
 
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
2020 Transplant Immunogenicity Calculator : Fiction or Reality? - prof. Ahmed...
 
Genome mapping
Genome mapping Genome mapping
Genome mapping
 
Polymerase Chain Reaction
Polymerase Chain ReactionPolymerase Chain Reaction
Polymerase Chain Reaction
 
Pcr and its applications in cloning
Pcr and its applications in cloningPcr and its applications in cloning
Pcr and its applications in cloning
 
Ngs pgd
Ngs pgdNgs pgd
Ngs pgd
 
Ngs pgd
Ngs pgdNgs pgd
Ngs pgd
 
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITEDSelene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
 
antiviral coursework
antiviral courseworkantiviral coursework
antiviral coursework
 
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
 
Impact_of_gene_length_on_DEG
Impact_of_gene_length_on_DEGImpact_of_gene_length_on_DEG
Impact_of_gene_length_on_DEG
 
3.5 part 1
3.5 part 13.5 part 1
3.5 part 1
 
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
 
-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf
 
-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf-DNA Sequencing Notes.pdf
-DNA Sequencing Notes.pdf
 
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...
Validation of rare Variants in the Schizophrenia-linked gene DPYSL2 - Fatuma ...
 

Abstract (1)

  • 1. Creating a Targeted Next Generation Sequencing Assay to Identify RH antigens from DNA for Stem Cell Transplants Abigail Joseph Principal Investigator:​ William Lane MD, PhD Mentors:​ Peter Tonellato PhD; Helen Mah, MS; John ​Baronas Dana-Farber Cancer Institute Using DNA assays to determine human leukocyte antigen (HLA) type is standard practice when seeking to find stem cell transplant donor matches. Recently, next generation sequencing (NGS) has been successfully developed to perform accurate HLA typing. As a result, stem cell donors are typed using DNA samples collected with cheek swab kits. ABO and Rh mismatches between donor and recipient can result in major and minor incompatibilities that can delay erythroid engraftment and require multiple rounds of red blood cell (RBC) transfusions. An ABO and Rh NGS assay could improve the stem cell transplant matching process because only DNA samples are collected from prospective donors. However, one major obstacle in using NGS to determine the presence of Rh antigens from DNA is the similarity between the ​RHD and ​RHCE genes. The objective of our experiment was to determine whether a targeted NGS assay could be developed to determine the specific Rh antigens in a patient’s RBCs. We performed long range PCRs to test optimal primer combinations for successful amplification of the genes. Gene specific indexes were added to the ​RHD and ​RHCE PCR products, prior to sequencing, so identical regions of the genes could be clearly labeled. The results of the sequence alignments showed that the primers that targeted ​RHD exons 1-6 and ​RHCE exons 1-4 resulted in the largest PCR products while maintaining strong alignment coverage. In addition, the DNA reads aligned according to our expectations allowing us to predict the patient’s antigen type as D antigen positive, homozygous for the C antigen, and homozygous for the e antigen. These findings suggest that Rh antigens can be determined from DNA assays without serologic testing. Consequently, the same DNA sample used for HLA typing can be used for Rh antigen typing, thus streamlining the stem cell donor match process.
  • 2. Currently HLA (human Leukocyte Antigen) typing is done completely from DNA ● However, RBC antigens still cannot be determined from DNA and must be confirmed serologically ● This hinders the process of finding donors for Stem Cell Transplant, ○ Although a DNA sample, such as spit or cheek cells, that are sent in can be used to determine a potential donor's HLA type, that same sample can’t be used to determine RBC type ○ Donor must physically come in to donate blood and test must be done serologically, which is time consuming and expensive ● This is especially relevant for patients with leukemia or Lymphoma who need Stem Cell Transplants since their immune systems were eliminated in the treatment process ● There is a need to find exact matches or else the patient is at risk for HTR (hemolytic Transfusion Reaction) or GvHD (Graft vs. Host Disease)
  • 3. ● Purpose is to create a targeted assay that uses Next Generation Sequencing to confirm RH, RhD and RhCE, antigens on RBC similar to how HLAs are confirmed ● Then theoretically one DNA sample could be used to find the most promising exact HLA and RBC antigen matches, so only a few would have to be brought in for serologically confirmation of the DNA results. ● Problem with current attempts to sequence the RhD and RhCE is that they are very similar gene and standard methods of hybrid capture and amplicon sequencing do not work ○ Some parts of RhD and RhCE are so similar so sequencing without long enoug reads can fail to identify which DNA come from RhD and which from RhCE ● The approach we used is very long range PCR ○ It can create gene specific sequences, which circumvents the problem that the genes look very similar ○ By allowing us to add gene specific tags so we can know which gene it came from when sequencing ● First step is find a primer that would amplify the Rhd gene DNA ○ Looked at PCR products to determine size and quantity ● Next the goal is to sequence the DNA, using an illumina miseq, ● Take sequencing data dn see which genes they align to ● Last is to examine the sequencing data using a software to determine whether the sequencing allows us to conclude that the someone has an RhD antigen or if the sequencing is inconclusive http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926707/ Picture http://fce-study.netdna-ssl.com/2/images/upload-flashcards/10/70/84/9107084_m.jpg http://img.medscapestatic.com/pi/meds/ckb/47/9947tn.jpg
  • 5. Presentation I. Intro A. What are the consequences of not matching type when giving stem cell transplants 1. Stem Cell transplants are typically given to leukemia and lymphoma cancer patients, who have had their immune systems destroyed by treatment and need the transplants to replenish their immune system 2. GvHD (graft vs. Host Disease) a) Diseases can be fatal 3. HDFN or HTR for RBC B. How can DNA help provide more accurate blood typing? 1. For the past 5 yrs HLA (human leukocyte antigens) aka white blood cell antigens have been typed completely from DNA 2. No longer needs to be done serologically, time consuming process, prone to human error, expensive lab procedures and reagents 3. However RBC (red blood cell) typing still cannot be confirmed from a DNA sample but must be tested serologically C. Our question 1. We chose to look at the RhD and RhCE antigens, to determine whether we could create a targeted NGS assay to reliably determine the D, C, c, E, e antigens present on a patient's RBC from a DNA smaple a) Explain what D anitgen is, determine (+) or (-) blood type 2. These antigens are especially problematic to determine with DNA sequencing because they are very similar to each other, they can even containing completely identical exons, and often sequences from one gene can align to another, for accurate typing it is essential that reads (sequences) align to the appropriate gene II. Set Up -​ ask for Illumina Prep procedure A. Before we could sequence the RhD and RhCE genes we had to determine which primers would give us the highest concentration of the genes and the most accurate “cuts” 1. We focused only on the first 7 exons in both - ​WHY B. Performed 12 very long range PCR for each RhD and RhCE with different primers, and used a gel to determine how much volume was produced, and a standard to approximate the length of the DNA strands 1. Show image of PCR explain how each well increases in size as it contains more exons C. Before putting the the DNA in the Illumina miseq, we tagged the DNA that was Rhd and that was RhCE, with different tags, so at the end of the process we know which DNA came from where 1. How does the tagging work???
  • 6. D. The Illumina miseq take about 22 hrs to sequence the gene and then we download the data into IGV (Integrative Genomics Viewer) to analyze the success of each of the different primer set combinations III. Data and Interpretation A. Show the what the RhD and RhCE look like on one of the most successful trials and one of the mediocre trials 1. Explain how to tell whether someone has high or low coverage 2. Maybe how to determine their genotype from the one base pair 3. Explain why there might be low coverage a) Misalignment - graphic from Dr. Lanes Slide IV. Context and Importance and Future Directions A. Only 1 of the more than 300 RBC antigens, however it's the most important antigen after the ABO group B. When searching for Donors, in the future one sample of spit or cheek swab would allow a doctor to determine your entire specific blood type,